Cleared Abbreviated

INTELLIVUE PATIENT MONITOR (K120366) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2012
Decision
163d
Days
Class 2
Risk

K120366 is an FDA 510(k) clearance for the INTELLIVUE PATIENT MONITOR. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Philips Medizinsysteme Boeblingen GmbH, Cardiac AN (Boeblingen, Baden-Wuerttemberg, DE). The FDA issued a Cleared decision on July 18, 2012 after a review of 163 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Philips Medizinsysteme Boeblingen GmbH, Cardiac AN devices

Submission Details

510(k) Number K120366 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2012
Decision Date July 18, 2012
Days to Decision 163 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 125d · This submission: 163d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 197
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K120366.
IMEC, IPM AND BENEVIEW T1 PATIENT MONITORS
K123074 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2013
MFM-CMS CENTRAL MONITORING SYSTEM
K120727 · Edan Instruments, Inc. · Jun 2013
SURESIGNS VM4, SURESIGNS VM6, SURESIGNS VM8
K123900 · Philips Medical Systems · Apr 2013
PATIENT MONITOR
K120173 · Edan Instruments, Inc. · May 2012
PATIENT MONITOR
K113653 · Edan Instruments, Inc. · Feb 2012
PATIENT MONITOR
K113623 · Edan Instruments, Inc. · Feb 2012